HopeStage
Back to all studies
SuspendedNCT05091580

Effectiveness and Cost-Effectiveness of Depression Treatment for Individuals With TB in South Africa

Behavioural studyAges 18+South Africa
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Cape TownSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 24, 2023
Recruitment status
Suspended
Enrollment listed in the registry
500
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Behavioral
Intervention type
Behavioural
Locations
South Africa
Age range
Over 18 Years
Official registry ID
NCT05091580
Official title
Show the full official title

The Effectiveness and Cost-effectiveness of Implementing Evidence-based Depression Treatment Within the TB Care Platform in South Africa: A Hybrid Effectiveness-implementation Trial

Recruitment & locations

Suspended

Cape Town

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as suspended.

Want to explore more studies?

Explore studies